Recently, it has been published how G9a inhibition impairs cell cancer division and promotes cell death by inducing interferon-mediated genes and immunogenic response in several hematological malignancies, including AML and ALL [29]. The gene discussed is EHMT2; the disease is acute myeloid leukemia.